CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Inter Pharma PCL is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Inter Pharma PCL
140/9 ITF Tower 9th Floor
Silom Road, Suriyawong
Phone: +66 26340225p:+66 26340225 BANGKOK, 10500  Thailand Ticker: IPIP
Business Summary
Inter Pharma Public Company Limited is a Thailand-based biopharmaceutical company. The Company is principally engaged in the importing, manufacturing and distribution of dietary supplement product for humans and animals. It provides wellness and anti-aging products, aesthetic innovation products, animal health products and livestock products. The Company's segment includes Human healthcare, animal healthcare, and Hospital. Its wellness and anti-aging products include Probac7, Probac10 plus, TS6, Beta Glucan Plus, Pure Krill Oil, Astacurmin and YUUU Cleansing Mousse. Its aesthetic innovation products include Perfectha Complement, Perfectha Derm, Perfectha Deep and Perfectha Subskin. The Company's animal health products include Dr.Choice Cal-B, Dr.Choice Cardi-B, Petinol, Pet Select Senior, Pet Select Osteoflex and Malaseb Shampoo for dogs and cats. It also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., and Modern Pharma Co., Ltd.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries
8062 General medical and surgical hospitals

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board UdomKochinthorn
Chief Executive Officer, Director Songsawut SakChalathorn
Vice President - Accounting and Finance, Director Supaporn A.Phithakpanit
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 282 (As of 12/31/2021)
Outstanding Shares: 372,520,524 (As of 12/31/2023)
Stock Exchange: BAK
Fax Number: +66 26340135


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024